These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24418286)

  • 1. Contrast-enhanced CT and diffusion-weighted MR imaging: performance as a prognostic factor in patients with pancreatic ductal adenocarcinoma.
    Fukukura Y; Takumi K; Higashi M; Shinchi H; Kamimura K; Yoneyama T; Tateyama A
    Eur J Radiol; 2014 Apr; 83(4):612-9. PubMed ID: 24418286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of apparent diffusion coefficient obtained by diffusion-weighted MRI in pancreatic cancer.
    Kurosawa J; Tawada K; Mikata R; Ishihara T; Tsuyuguchi T; Saito M; Shimofusa R; Yoshitomi H; Ohtsuka M; Miyazaki M; Yokosuka O
    J Magn Reson Imaging; 2015 Dec; 42(6):1532-7. PubMed ID: 25946483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
    Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
    J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
    Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
    Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic adenocarcinoma: variability of diffusion-weighted MR imaging findings.
    Fukukura Y; Takumi K; Kamimura K; Shindo T; Kumagae Y; Tateyama A; Nakajo M
    Radiology; 2012 Jun; 263(3):732-40. PubMed ID: 22623694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations.
    Kim JH; Park SH; Yu ES; Kim MH; Kim J; Byun JH; Lee SS; Hwang HJ; Hwang JY; Lee SS; Lee MG
    Radiology; 2010 Oct; 257(1):87-96. PubMed ID: 20697118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging features of small (≤ 3 cm) pancreatic solid tumors on gadoxetic-acid-enhanced MR imaging and diffusion-weighted imaging: an initial experience.
    Jang KM; Kim SH; Kim YK; Park MJ; Lee MH; Hwang J; Rhim H
    Magn Reson Imaging; 2012 Sep; 30(7):916-25. PubMed ID: 22495239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Grützmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of vascular involvement and resectability by multidetector-row CT versus MR imaging with MR angiography in patients who underwent surgery for resection of pancreatic ductal adenocarcinoma.
    Lee JK; Kim AY; Kim PN; Lee MG; Ha HK
    Eur J Radiol; 2010 Feb; 73(2):310-6. PubMed ID: 19070981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma.
    Kim YI; Kim SK; Paeng JC; Lee HY
    Eur J Radiol; 2014 Jan; 83(1):231-5. PubMed ID: 24290142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of ADC measurements among solid pancreatic masses by respiratory-triggered diffusion-weighted MR imaging with inversion-recovery fat-suppression technique at 3.0T.
    Yao XZ; Yun H; Zeng MS; Wang H; Sun F; Rao SX; Ji Y
    Magn Reson Imaging; 2013 May; 31(4):524-8. PubMed ID: 23200681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
    Kamel IR; Bluemke DA; Eng J; Liapi E; Messersmith W; Reyes DK; Geschwind JF
    J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual enhancement pattern during the delayed phase of enhanced CT as an independent prognostic factor in stage IV pancreatic ductal adenocarcinoma.
    Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nagano H; Hidaka S; Kamimura K; Maemura K; Arima S; Yoshiura T
    Pancreatology; 2020 Sep; 20(6):1155-1163. PubMed ID: 32800574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted magnetic resonance imaging of pancreatic adenocarcinomas: association with histopathology and tumor grade.
    Wang Y; Chen ZE; Nikolaidis P; McCarthy RJ; Merrick L; Sternick LA; Horowitz JM; Yaghmai V; Miller FH
    J Magn Reson Imaging; 2011 Jan; 33(1):136-42. PubMed ID: 21182131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Missed pancreatic ductal adenocarcinoma: Assessment of early imaging findings on prediagnostic magnetic resonance imaging.
    Jang KM; Kim SH; Kim YK; Song KD; Lee SJ; Choi D
    Eur J Radiol; 2015 Aug; 84(8):1473-1479. PubMed ID: 26032128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of gadolinium chelate contrast agent on diffusion-weighted imaging of pancreatic ductal adenocarcinoma.
    Liu K; Peng W; Zhou Z
    Acta Radiol; 2013 May; 54(4):364-8. PubMed ID: 23386737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/MRI in pancreatic and periampullary cancer: correlating diffusion-weighted imaging, MR spectroscopy and glucose metabolic activity with clinical stage and prognosis.
    Chen BB; Tien YW; Chang MC; Cheng MF; Chang YT; Wu CH; Chen XJ; Kuo TC; Yang SH; Shih IL; Lai HS; Shih TT
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1753-64. PubMed ID: 26993317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucin-producing tumor of the pancreas: diagnostic value of diffusion-weighted echo-planar MR imaging.
    Yamashita Y; Namimoto T; Mitsuzaki K; Urata J; Tsuchigame T; Takahashi M; Ogawa M
    Radiology; 1998 Sep; 208(3):605-9. PubMed ID: 9722835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-small cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging.
    Yabuuchi H; Hatakenaka M; Takayama K; Matsuo Y; Sunami S; Kamitani T; Jinnouchi M; Sakai S; Nakanishi Y; Honda H
    Radiology; 2011 Nov; 261(2):598-604. PubMed ID: 21852569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging.
    Murakami R; Sugahara T; Nakamura H; Hirai T; Kitajima M; Hayashida Y; Baba Y; Oya N; Kuratsu J; Yamashita Y
    Radiology; 2007 May; 243(2):493-9. PubMed ID: 17356177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.